Red Spruce Capital, LLC Eli Lilly & CO Transaction History

Red Spruce Capital, LLC

$209 Million
Q2 2024

A detailed history of Red Spruce Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Red Spruce Capital, LLC holds 2,365 shares of LLY stock, worth $2.16 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

2,365

Previous 2,391 1.09%

Holding current value

$2.16 Million

Previous $1.86 Million 15.11%

% of portfolio

1.03%

Previous 0.89%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 02, 2024	SELL	$724.87 - $909.04 $18,846 - $23,635	-26 Reduced 1.09%	2,365 $2.14 Million
Q1 2024 Apr 10, 2024	SELL	$592.2 - $792.28 $416,316 - $556,972	-703 Reduced 22.72%	2,391 $1.86 Million
Q4 2023 Jan 05, 2024	SELL	$525.19 - $619.13 $52,519 - $61,913	-100 Reduced 3.13%	3,094 $1.8 Million
Q3 2023 Oct 03, 2023	SELL	$434.7 - $599.3 $104,328 - $143,832	-240 Reduced 6.99%	3,194 $1.72 Million
Q2 2023 Jul 05, 2023	SELL	$350.74 - $468.98 $11,574 - $15,476	-33 Reduced 0.95%	3,434 $1.61 Million

Q1 2023 Apr 06, 2023	SELL	$310.63 - $364.82 $36,343 - $42,683	-117 Reduced 3.26%	3,467 $1.19 Million
Q4 2022 Jan 03, 2023	BUY	$321.55 - $374.67 $1,286 - $1,498	4 Added 0.11%	3,584 $0
Q3 2022 Oct 03, 2022	SELL	$296.48 - $337.87 $14,231 - $16,217	-48 Reduced 1.32%	3,580 $1.16 Million
Q1 2022 Apr 05, 2022	SELL	$234.69 - $291.66 $1.14 Million - $1.42 Million	-4,877 Reduced 57.34%	3,628 $1.04 Million
Q4 2021 Jan 03, 2022	SELL	$224.85 - $279.04 $1.08 Million - $1.34 Million	-4,810 Reduced 36.12%	8,505 $2.35 Million
Q3 2021 Oct 04, 2021	BUY	$221.6 - $272.71 $32,353 - $39,815	146 Added 1.11%	13,315 $3.08 Million
Q2 2021 Jul 06, 2021	SELL	$180.55 - $233.54 $80,525 - $104,158	-446 Reduced 3.28%	13,169 $3.02 Million
Q1 2021 Apr 01, 2021	BUY	$164.32 - $212.72 $39,929 - $51,690	243 Added 1.82%	13,615 $2.54 Million
Q4 2020 Jan 04, 2021	SELL	$130.46 - $172.63 $4,566 - $6,042	-35 Reduced 0.26%	13,372 $2.26 Million
Q3 2020 Oct 02, 2020	SELL	$146.22 - $169.13 $9,650 - $11,162	-66 Reduced 0.49%	13,407 $1.99 Million
Q2 2020 Jul 02, 2020	SELL	$136.42 - $164.18 $954 - $1,149	-7 Reduced 0.05%	13,473 $2.21 Million
Q1 2020 Apr 06, 2020	SELL	$119.05 - $147.35 $26,786 - $33,153	-225 Reduced 1.64%	13,480 $1.87 Million
Q4 2019 Jan 16, 2020	BUY	$106.92 - $132.43 $1.47 Million - $1.81 Million	13,705 New	13,705 $1.8 Million

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Spruce Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Spruce Capital, LLC with notifications on news.

Account

Red Spruce Capital, LLC Eli Lilly & CO Transaction History